Concepedia

Sulabha Ranganathan

SR

23

Publications

1.4K

Citations

19

H-Index

1987

Active since

Affiliations

Fox Chase Cancer Center(Current)

University of Alabama

The University of Texas MD Anderson Cancer Center

Sulabha Ranganathan is an author at Fox Chase Cancer Center specializing in medicine, biochemistry, and tumor biology.

Top concepts

Publications per year

1987–2019

23

Publications

23

Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

Sulabha Ranganathan, C A Benetatos, PJ Colarusso et al. · British Journal of Cancer · 1998 · 214 citations · Full text

, , +5

Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

Steven J. Cohen, Linus Ho, Sulabha Ranganathan et al. · Journal of Clinical Oncology · 2003 · 169 citations

Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.

Sulabha Ranganathan, D W Dexter, C A Benetatos et al. · PubMed · 1996 · 113 citations

, , +12

Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.

Gary R. Hudes, Christine E. Szarka, Andrea L. Adams et al. · PubMed · 2000 · 98 citations

, , +14

Cloning and characterization of human colon glyoxalase-I.

Sulabha Ranganathan, Eileen S. Walsh, Andrew K. Godwin et al. · Journal of Biological Chemistry · 1993 · 84 citations · Full text

, , +17

Rows per page

1–5 of 23